Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Western Pac Surveill Response J ; 13(1): 1-4, 2022.
Article in English | MEDLINE | ID: covidwho-1687325

ABSTRACT

In any infectious disease outbreak, early diagnosis, isolation of cases and quarantine of contacts are central to disease containment. In Brunei Darussalam, suspected cases of coronavirus disease 2019 (COVID-19) were quarantined either at home or at designated centres and were tested immediately for severe acute respiratory syndrome coronavirus 2. We report on 10 cases of COVID-19 that initially tested negative for COVID-19 and were positive on re-testing after becoming symptomatic. These cases comprised 3.8% of the 266 total confirmed COVID-19 cases in Brunei Darussalam as of 9 July 2021, when this study was conducted. All the cases were in quarantine at home and were tested early during their quarantine period. Since then, home quarantine has been replaced by quarantine at designated centres only, with testing on the 12th day of quarantine.


Subject(s)
COVID-19 , Brunei/epidemiology , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/prevention & control , Humans , Mass Screening , Negative Results , Quarantine
2.
J Med Virol ; 92(11): 2847-2851, 2020 11.
Article in English | MEDLINE | ID: covidwho-935152

ABSTRACT

Case reports of patients with coronavirus disease-2019 (COVID-19) who have been discharged and subsequently report positive reverse transcription-polymerase chain reaction again (hereafter referred as "re-positive") do not fully describe the magnitude and significance of this issue. To determine the re-positive rate (proportion) and review probable causes and outcomes, we conduct a retrospective study of all 119 discharged patients in Brunei Darussalam up till April 23. Patients who were discharged are required to self-isolate at home for 14 days and undergo nasopharyngeal specimen collection postdischarge. Discharged patients found to be re-positive were readmitted. We reviewed the clinical and epidemiological records of all discharged patients and apply log-binomial models to obtain risk ratios for re-positive status. One in five recovered patients subsequently test positive again for severe acute respiratory syndrome coronavirus 2-this risk is more than six times higher in persons aged 60 years and above. The average Ct value of re-positive patients was lower predischarge compared with their readmission Ct value. Out of 111 close contacts tested, none were found to be positive as a result of exposure to a re-positive patient. Our findings support prolonged but intermittent viral shedding as the probable cause for this phenomenon. We did not observe infectivity potential in these patients.


Subject(s)
COVID-19 Serological Testing/statistics & numerical data , COVID-19/diagnosis , Immunoassay/statistics & numerical data , Patient Discharge/statistics & numerical data , Adolescent , Adult , Aged , Brunei , COVID-19/immunology , Child, Preschool , Female , Humans , Male , Middle Aged , Nasopharynx/virology , Retrospective Studies , Risk Factors , Specimen Handling , Time Factors , Virus Shedding , Young Adult
3.
Am J Trop Med Hyg ; 103(1): 79-82, 2020 07.
Article in English | MEDLINE | ID: covidwho-822291

ABSTRACT

Novel coronavirus disease (COVID-19) is a highly contagious disease caused by severe acute respiratory distress syndrome coronavirus-2 that has resulted in the current global pandemic. Currently, there is no available treatment proven to be effective against COVID-19, but multiple medications, including hydroxychloroquine (HCQ), are used off label. We report the case of a 60-year-old woman without any cardiac history who developed right bundle brunch block and critically prolonged corrected electrocardiographic QT interval (QTc 631 ms) after treatment for 3 days with HCQ, which resolved on discontinuation of the medication. This case highlights a significant and potentially life-threatening complication of HCQ use.


Subject(s)
Bundle-Branch Block/chemically induced , Coronavirus Infections/drug therapy , Hydroxychloroquine/adverse effects , Hydroxychloroquine/therapeutic use , Long QT Syndrome/chemically induced , Pneumonia, Viral/drug therapy , Betacoronavirus , Brunei , COVID-19 , Echocardiography , Female , Humans , Middle Aged , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL